These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22390562)

  • 41. Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease.
    Jiang H; Chen C; Gao J
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma levels of the cardiovascular protective endogenous nucleoside adenosine are reduced in patients with primary aldosteronism without affecting ischaemia-reperfusion injury: A prospective case-control study.
    van den Berg TNAD; Thijssen DHJ; van Mil ACCM; van den Broek PH; Rongen GA; Monajemi H; Deinum J; Riksen NP
    Eur J Clin Invest; 2019 Dec; 49(12):e13180. PubMed ID: 31659743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD39-adenosinergic axis in renal pathophysiology and therapeutics.
    Kishore BK; Robson SC; Dwyer KM
    Purinergic Signal; 2018 Jun; 14(2):109-120. PubMed ID: 29332180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ticagrelor Does Not Inhibit Adenosine Transport at Relevant Concentrations: A Randomized Cross-Over Study in Healthy Subjects In Vivo.
    van den Berg TN; El Messaoudi S; Rongen GA; van den Broek PH; Bilos A; Donders AR; Gomes ME; Riksen NP
    PLoS One; 2015; 10(10):e0137560. PubMed ID: 26509673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of eplerenone on adenosine formation in humans in vivo: a double-blinded randomised controlled study.
    van den Berg TN; Deinum J; Bilos A; Donders AR; Rongen GA; Riksen NP
    PLoS One; 2014; 9(10):e111248. PubMed ID: 25356826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.
    Jacobson KA
    J Med Chem; 2013 May; 56(10):3749-67. PubMed ID: 23597047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unveiling the binding mode of adenosine deaminase inhibitors to the active site of the enzyme: implication for rational drug design : presented by Maria P. Abbracchio.
    Trincavelli ML
    Purinergic Signal; 2013 Mar; 9(1):1-3. PubMed ID: 23355190
    [No Abstract]   [Full Text] [Related]  

  • 48. Remote postconditioning may attenuate ischaemia-reperfusion injury in the murine hindlimb through adenosine receptor activation.
    Tsubota H; Marui A; Esaki J; Bir SC; Ikeda T; Sakata R
    Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):804-9. PubMed ID: 20869891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cardiovascular effects of adenosine: clinical use and nursing implications.
    Teplitz L
    Prog Cardiovasc Nurs; 1993; 8(2):20-8. PubMed ID: 7937680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting adenosine receptors in the development of cardiovascular therapeutics.
    Riksen NP; Rongen GA
    Expert Rev Clin Pharmacol; 2012 Mar; 5(2):199-218. PubMed ID: 22390562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.
    Shryock JC; Belardinelli L
    Am J Cardiol; 1997 Jun; 79(12A):2-10. PubMed ID: 9223356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosinergic cardioprotection: multiple receptors, multiple pathways.
    Peart JN; Headrick JP
    Pharmacol Ther; 2007 May; 114(2):208-21. PubMed ID: 17408751
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.